Skip to content

Eqwal Care

Active
Public limited companyfounded 20188 years activeHerman Teirlinckstraat 15, 9041 Gent, BelgiumKBO/BCE: BE 0707.608.763
Summary

Eqwal Care has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.1m and a net result of €935,873. Equity remains stable across the filed fiscal years (±1% per year). Its solvency ranks better than 48% of 12,411 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Overview

Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741Wholesale of pharmaceutical and medical goods NACE 46460
3 sites
Size
€6.1mtotal assets 2025
Staff
24.5 FTE
Equity
€2.1m
Profit
€935,873
Net result +74%: 12-month year
Financial health
81 Excellent Checked score 2025
Bankruptcy probability, 12 months
0.5%
Structure
Parent
FINICOMA · 100%
Accounts 9 days early4 of 20 deeds read
Why 81- 1 of the last 3 late- Founded in 2018+ Size: 24.5 FTE, total assets €6.1m+ Figures for FY 2025 (filed 24-04-2026)Show the evidence

Checked score

Score 2025
81 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 49% of its sector peers (NACE 47, small)
Financial strength · tick = 2024
Strong
Solvency 60-5
equity 35.1% of total assets
Liquidity 34+1
short-term debt 54.6% · cash 9.7%
Profitability 88+9
return on assets 15.4%
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (3,686 companies)
Last 24 months 11-2024: 1.7%highest value 12-2024: 1.7%● unchanged vs 11-2024highest value 01-2025: 1.5%▼ -0.2 percentage points vs 12-2024 02-2025: 1.4%▼ -0.1 percentage points vs 01-2025 03-2025: 1.4%● unchanged vs 02-2025 04-2025: 1.5%▲ +0.1 percentage points vs 03-2025 05-2025: 0.8%▼ -0.7 percentage points vs 04-2025 06-2025: 0.8%● unchanged vs 05-2025 07-2025: 0.8%● unchanged vs 06-2025 08-2025: 0.8%● unchanged vs 07-2025 09-2025: 0.8%● unchanged vs 08-2025 10-2025: 0.8%● unchanged vs 09-2025 11-2025: 0.8%● unchanged vs 10-2025 12-2025: 0.8%● unchanged vs 11-2025 01-2026: 0.9%▲ +0.1 percentage points vs 12-2025 02-2026: 0.6%▼ -0.3 percentage points vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.7%▲ +0.1 percentage points vs 03-2026 05-2026: 0.6%▼ -0.1 percentage points vs 04-2026 06-2026: 0.6%● unchanged vs 05-2026 07-2026: 0.5%▼ -0.1 percentage points vs 06-2026 08-2026: 0.5%● unchanged vs 07-2026 09-2026: 0.5%● unchanged vs 08-2026 10-2026: 0.5%● unchanged vs 09-2026lowest value
Credit up to €170,000 at 30 days acceptable
Liquidity short (current ratio 0.99 against 1.0 in 2024; short-term debt: 54.6% and cash: 9.7% of total assets), and 64.9% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small): better than 55% on solvency, 36% on liquidity, 90% on profitability and 16% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
raises risk · 1 of the last 3 late
NBB · filings
lowers risk · Size: 24.5 FTE, total assets €6.1m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Founded in 2018
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
lowers risk · Figures for FY 2025 (filed 24-04-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 21-04-2026, 9 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
9 days early
2024
8 days early
2023
34 days late
2022
28 days early
2021
17 days early
2020
23 days early
2019
90 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 6 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-09-2026 close07-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Capital & shares · RestructuringMerger · Declaration · Share…
  2. Capital & shares · RestructuringMerger · Declaration · Real…
  3. Annual accounts filedfiscal year 2025 · abbreviated…

Key points

  • Positive: Among the best 5% on net resultsector median €28,351 · 12,399 companies €935,873 View
  • Result rose in 202512-month fiscal year ▲ 73.7% View
  • 2 restructurings since 2026latest: branch taken over from DYNA-MEDICAL 2 View
  • Controlled by FINICOMAultimately: Ovalie Développement 4 100% View

By topic

Financials

Fiscal year
2025
Total assets
€6.1m
Profit
€935,873
Solvency
35.1%
Turnover▲ 9.9%
Net result
20192023
Go to Financials

Timeline

Events
14
Since
2020
Next accounts
by 30-04-2027
  1. 19-02-2026Miscellaneous
  2. 20-11-2025Miscellaneous
  3. 30-09-2025Highest result since 2019
Go to Timeline

Company details

Sites
3
Legal form
Public limited company
Activity
Retail sale of medical and orthopaedic goods, excluding…NACE 47741
Founded
02-10-2018
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
10
Purpose
Alle activiteiten die gewoonlijk worden verricht en uitgevoerd door verkoopagentschappen…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.